Femasys Share Price
NASDAQ: FEMY | HealthcareFemasys Stock Performance
Femasys Share Price Chart
Femasys Quarterly Profit & Loss
All figures in USD
Femasys Annual Profit & Loss
All figures in USD
Femasys Balance Sheet
All figures in USD Million
Femasys Cash Flow
All figures in USD Million
Corporate Actions
About Femasys
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Femasys Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.35 | $1.24 | -9.49% |
Oct 2026 | $2.18 | $1.37 | -36.57% |
Sep 2026 | $3.35 | $2.16 | -23.27% |
Aug 2026 | $2.95 | $2.81 | -4.09% |
Jul 2026 | $4.28 | $2.94 | -21.73% |
Jun 2026 | $0.37 | $3.75 | +900.00% |
May 2026 | $0.37 | $0.38 | +1.90% |
Apr 2026 | $0.44 | $0.37 | -12.80% |
Mar 2026 | $0.55 | $0.42 | -25.83% |
Feb 2026 | $0.53 | $0.57 | +5.18% |
Jan 2026 | $0.62 | $0.54 | -5.75% |
Dec 2025 | $0.95 | $0.57 | -44.00% |